CGEN
Compugen Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.59
+1.37%Aug 3, 2026, 11:00 UTC
Compugen reported its financial results for the second quarter of 2026, highlighting a solid financial position with cash runway expected to fund operations into 2029.